These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 9233635

  • 1. The hepatitis B virus-specific CTL responses induced in humans by lipopeptide vaccination are comparable to those elicited by acute viral infection.
    Livingston BD, Crimi C, Grey H, Ishioka G, Chisari FV, Fikes J, Grey H, Chesnut RW, Sette A.
    J Immunol; 1997 Aug 01; 159(3):1383-92. PubMed ID: 9233635
    [Abstract] [Full Text] [Related]

  • 2. Altered helper T lymphocyte function associated with chronic hepatitis B virus infection and its role in response to therapeutic vaccination in humans.
    Livingston BD, Alexander J, Crimi C, Oseroff C, Celis E, Daly K, Guidotti LG, Chisari FV, Fikes J, Chesnut RW, Sette A.
    J Immunol; 1999 Mar 01; 162(5):3088-95. PubMed ID: 10072562
    [Abstract] [Full Text] [Related]

  • 3. HLA A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection.
    Nayersina R, Fowler P, Guilhot S, Missale G, Cerny A, Schlicht HJ, Vitiello A, Chesnut R, Person JL, Redeker AG, Chisari FV.
    J Immunol; 1993 May 15; 150(10):4659-71. PubMed ID: 7683326
    [Abstract] [Full Text] [Related]

  • 4. Pools of lipidated HTL-CTL constructs prime for multiple HBV and HCV CTL epitope responses.
    Oseroff C, Sette A, Wentworth P, Celis E, Maewal A, Dahlberg C, Fikes J, Kubo RT, Chesnut RW, Grey HM, Alexander J.
    Vaccine; 1998 May 15; 16(8):823-33. PubMed ID: 9627940
    [Abstract] [Full Text] [Related]

  • 5. Endoplasmic reticulum targeting sequence enhances HBV-specific cytotoxic T lymphocytes induced by a CTL epitope-based DNA vaccine.
    Xu W, Chu Y, Zhang R, Xu H, Wang Y, Xiong S.
    Virology; 2005 Apr 10; 334(2):255-63. PubMed ID: 15780875
    [Abstract] [Full Text] [Related]

  • 6. Molecular features of the hepatitis B virus nucleocapsid T-cell epitope 18-27: interaction with HLA and T-cell receptor.
    Bertoletti A, Southwood S, Chesnut R, Sette A, Falco M, Ferrara GB, Penna A, Boni C, Fiaccadori F, Ferrari C.
    Hepatology; 1997 Oct 10; 26(4):1027-34. PubMed ID: 9328331
    [Abstract] [Full Text] [Related]

  • 7. Delivery of multiple CD8 cytotoxic T cell epitopes by DNA vaccination.
    Thomson SA, Sherritt MA, Medveczky J, Elliott SL, Moss DJ, Fernando GJ, Brown LE, Suhrbier A.
    J Immunol; 1998 Feb 15; 160(4):1717-23. PubMed ID: 9469429
    [Abstract] [Full Text] [Related]

  • 8. A novel HBV DNA vaccine based on T cell epitopes and its potential therapeutic effect in HBV transgenic mice.
    Li X, Yang X, Jiang Y, Liu J.
    Int Immunol; 2005 Oct 15; 17(10):1293-302. PubMed ID: 16113237
    [Abstract] [Full Text] [Related]

  • 9. Cytotoxic T lymphocyte response induced by an improved synthetic lipopeptide vaccine against cervical cancer.
    Xu DH, Zhou CH, Xia YP, Qiu ZY, Wu YZ, Jia ZC, Zhou W.
    Acta Pharmacol Sin; 2007 May 15; 28(5):695-702. PubMed ID: 17439726
    [Abstract] [Full Text] [Related]

  • 10. A pilot study of the CY-1899 T-cell vaccine in subjects chronically infected with hepatitis B virus. The CY1899 T Cell Vaccine Study Group.
    Heathcote J, McHutchison J, Lee S, Tong M, Benner K, Minuk G, Wright T, Fikes J, Livingston B, Sette A, Chestnut R.
    Hepatology; 1999 Aug 15; 30(2):531-6. PubMed ID: 10421664
    [Abstract] [Full Text] [Related]

  • 11. Utilization of MHC class I transgenic mice for development of minigene DNA vaccines encoding multiple HLA-restricted CTL epitopes.
    Ishioka GY, Fikes J, Hermanson G, Livingston B, Crimi C, Qin M, del Guercio MF, Oseroff C, Dahlberg C, Alexander J, Chesnut RW, Sette A.
    J Immunol; 1999 Apr 01; 162(7):3915-25. PubMed ID: 10201910
    [Abstract] [Full Text] [Related]

  • 12. DNA immunization induces antibody and cytotoxic T cell responses to hepatitis B core antigen in H-2b mice.
    Kuhöber A, Pudollek HP, Reifenberg K, Chisari FV, Schlicht HJ, Reimann J, Schirmbeck R.
    J Immunol; 1996 May 15; 156(10):3687-95. PubMed ID: 8621903
    [Abstract] [Full Text] [Related]

  • 13. Development of a lipopeptide-based therapeutic vaccine to treat chronic HBV infection. I. Induction of a primary cytotoxic T lymphocyte response in humans.
    Vitiello A, Ishioka G, Grey HM, Rose R, Farness P, LaFond R, Yuan L, Chisari FV, Furze J, Bartholomeuz R.
    J Clin Invest; 1995 Jan 15; 95(1):341-9. PubMed ID: 7814635
    [Abstract] [Full Text] [Related]

  • 14. Immunization with the HBV core 18-27 epitope elicits CTL responses in humans expressing different HLA-A2 supertype molecules.
    Livingston BD, Crimi C, Fikes J, Chesnut RW, Sidney J, Sette A.
    Hum Immunol; 1999 Nov 15; 60(11):1013-7. PubMed ID: 10599997
    [Abstract] [Full Text] [Related]

  • 15. Identification of HLA-A3 and -B7-restricted CTL response to hepatitis C virus in patients with acute and chronic hepatitis C.
    Chang KM, Gruener NH, Southwood S, Sidney J, Pape GR, Chisari FV, Sette A.
    J Immunol; 1999 Jan 15; 162(2):1156-64. PubMed ID: 9916747
    [Abstract] [Full Text] [Related]

  • 16. Hepatitis B surface antigen vector delivers protective cytotoxic T-lymphocyte responses to disease-relevant foreign epitopes.
    Woo WP, Doan T, Herd KA, Netter HJ, Tindle RW.
    J Virol; 2006 Apr 15; 80(8):3975-84. PubMed ID: 16571814
    [Abstract] [Full Text] [Related]

  • 17. Protective immunity against ocular herpes infection and disease induced by highly immunogenic self-adjuvanting glycoprotein D lipopeptide vaccines.
    Bettahi I, Nesburn AB, Yoon S, Zhang X, Mohebbi A, Sue V, Vanderberg A, Wechsler SL, BenMohamed L.
    Invest Ophthalmol Vis Sci; 2007 Oct 15; 48(10):4643-53. PubMed ID: 17898288
    [Abstract] [Full Text] [Related]

  • 18. Hepatitis C virus-derived lipopeptides differentially induce epitope-specific immune responses in vitro.
    Langhans B, Schweitzer S, Nischalke HD, Braunschweiger I, Sauerbruch T, Spengler U.
    J Infect Dis; 2004 Jan 15; 189(2):248-53. PubMed ID: 14722889
    [Abstract] [Full Text] [Related]

  • 19. Intranasal lipopeptide primes lung-resident memory CD8+ T cells for long-term pulmonary protection against influenza.
    Deliyannis G, Kedzierska K, Lau YF, Zeng W, Turner SJ, Jackson DC, Brown LE.
    Eur J Immunol; 2006 Mar 15; 36(3):770-8. PubMed ID: 16435281
    [Abstract] [Full Text] [Related]

  • 20. Human T-helper cell responses to a synthetic peptide derived from the hepatitis B surface antigen.
    Mishra A, Rao KV, Durgapal H, Manivel V, Panda SK.
    Immunology; 1993 Jul 15; 79(3):362-7. PubMed ID: 7691722
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.